Functional proteomics to dissect tyrosine kinase signalling pathways in cancer

Files in This Item:
File Description SizeFormat 
Paper55.pdf282.89 kBAdobe PDFDownload
Title: Functional proteomics to dissect tyrosine kinase signalling pathways in cancer
Authors: Kolch, Walter
Pitt, Andrew
Permanent link: http://hdl.handle.net/10197/5073
Date: 19-Aug-2010
Abstract: Advances in the generation and interpretation of proteomics data have spurred a transition from focusing on protein identification to functional analysis. Here we review recent proteomics results that have elucidated new aspects of the roles and regulation of signal transduction pathways in cancer using the epidermal growth factor receptor (EGFR), ERK and breakpoint cluster region (BCR)–ABL1 networks as examples. The emerging theme is to understand cancer signalling as networks of multiprotein machines which process information in a highly dynamic environment that is shaped by changing protein interactions and post-translational modifications (PTMs). Cancerous genetic mutations derange these protein networks in complex ways that are tractable by proteomics.
Type of material: Journal Article
Publisher: Nature Publishing Group
Copyright (published version): 2010 Nature Publishing Group
Keywords: Functional proteomics;signal transduction pathways;cancer;epidermal growth factor receptor (EGFR);ERK;breakpoint cluster region (BCR)–ABL1
DOI: 10.1038/nrc2900
Language: en
Status of Item: Peer reviewed
Appears in Collections:SBI Research Collection

Show full item record

SCOPUSTM   
Citations 1

129
Last Week
0
Last month
checked on Jun 23, 2018

Page view(s) 50

38
checked on May 25, 2018

Download(s) 50

83
checked on May 25, 2018

Google ScholarTM

Check

Altmetric


This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.